enVVeno Medical (NASDAQ:NVNO) Issues Earnings Results, Beats Expectations By $0.05 EPS

enVVeno Medical (NASDAQ:NVNO) posted its quarterly earnings data on Thursday. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Stock Down 9.9 %

enVVeno Medical stock traded down $0.35 during midday trading on Friday, reaching $3.18. The stock had a trading volume of 239,342 shares, compared to its average volume of 111,170. enVVeno Medical has a 52-week low of $2.45 and a 52-week high of $6.97. The firm has a market cap of $55.76 million, a price-to-earnings ratio of -2.47 and a beta of 1.22. The company has a fifty day moving average of $3.27 and a 200 day moving average of $3.70.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).